Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Long-Term Deferred Tax (2020)

Phio Pharmaceuticals' Long-Term Deferred Tax history spans 1 years, with the latest figure at $10.4 million for Q4 2020.

  • For Q4 2020, Long-Term Deferred Tax changed N/A year-over-year to $10.4 million; the TTM value through Dec 2020 reached $10.4 million, changed N/A, while the annual FY2020 figure was $10.4 million, N/A changed from the prior year.
  • Long-Term Deferred Tax reached $10.4 million in Q4 2020 per PHIO's latest filing.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $10.4 million in Q4 2020 to a low of $10.4 million in Q4 2020.